These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20888307)

  • 1. Inhaled mannitol in patients with cystic fibrosis: A randomised open-label dose response trial.
    Teper A; Jaques A; Charlton B
    J Cyst Fibros; 2011 Jan; 10(1):1-8. PubMed ID: 20888307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term inhaled dry powder mannitol in cystic fibrosis: an international randomized study.
    Aitken ML; Bellon G; De Boeck K; Flume PA; Fox HG; Geller DE; Haarman EG; Hebestreit HU; Lapey A; Schou IM; Zuckerman JB; Charlton B;
    Am J Respir Crit Care Med; 2012 Mar; 185(6):645-52. PubMed ID: 22198974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled mannitol for the treatment of cystic fibrosis.
    Hurt K; Bilton D
    Expert Rev Respir Med; 2012 Feb; 6(1):19-26. PubMed ID: 22283575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhaled dry powder mannitol in children with cystic fibrosis: A randomised efficacy and safety trial.
    De Boeck K; Haarman E; Hull J; Lands LC; Moeller A; Munck A; Riethmüller J; Tiddens H; Volpi S; Leadbetter J; Charlton B; Malfroot A;
    J Cyst Fibros; 2017 May; 16(3):380-387. PubMed ID: 28258928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled mannitol improves lung function in cystic fibrosis.
    Jaques A; Daviskas E; Turton JA; McKay K; Cooper P; Stirling RG; Robertson CF; Bye PTP; LeSouëf PN; Shadbolt B; Anderson SD; Charlton B
    Chest; 2008 Jun; 133(6):1388-1396. PubMed ID: 18339790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled dry powder mannitol in cystic fibrosis: an efficacy and safety study.
    Bilton D; Robinson P; Cooper P; Gallagher CG; Kolbe J; Fox H; Jaques A; Charlton B;
    Eur Respir J; 2011 Nov; 38(5):1071-80. PubMed ID: 21478216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of inhaled dry powder mannitol on mucus and its clearance.
    Daviskas E; Rubin BK
    Expert Rev Respir Med; 2013 Feb; 7(1):65-75. PubMed ID: 23362816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchial provocation testing with dry powder mannitol in children with cystic fibrosis.
    Minasian C; Wallis C; Metcalfe C; Bush A
    Pediatr Pulmonol; 2008 Nov; 43(11):1078-1084. PubMed ID: 18972410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effect of inhaled mannitol and cough in asthmatics with mucociliary dysfunction.
    Daviskas E; Anderson SD; Eberl S; Young IH
    Respir Med; 2010 Nov; 104(11):1645-53. PubMed ID: 20576419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled mannitol and cystic fibrosis. Unnecessary bronchial irritation.
    Prescrire Int; 2014 Apr; 23(148):89-91. PubMed ID: 24860889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mannitol dry powder for inhalation: in patients with cystic fibrosis.
    Burness CB; Keating GM
    Drugs; 2012 Jul; 72(10):1411-21. PubMed ID: 22755516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase 3 randomized study of the efficacy and safety of inhaled dry powder mannitol for the symptomatic treatment of non-cystic fibrosis bronchiectasis.
    Bilton D; Daviskas E; Anderson SD; Kolbe J; King G; Stirling RG; Thompson BR; Milne D; Charlton B;
    Chest; 2013 Jul; 144(1):215-225. PubMed ID: 23429964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial.
    Bilton D; Tino G; Barker AF; Chambers DC; De Soyza A; Dupont LJ; O'Dochartaigh C; van Haren EH; Vidal LO; Welte T; Fox HG; Wu J; Charlton B;
    Thorax; 2014 Dec; 69(12):1073-9. PubMed ID: 25246664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled mannitol in the treatment of non-cystic fibrosis bronchiectasis in adults.
    Gjoerup J; Hilberg O; Bendstrup E
    Respirology; 2012 Aug; 17(6):927-32. PubMed ID: 22564014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of inhaled mannitol on bronchial mucus clearance in cystic fibrosis patients: a pilot study.
    Robinson M; Daviskas E; Eberl S; Baker J; Chan HK; Anderson SD; Bye PT
    Eur Respir J; 1999 Sep; 14(3):678-85. PubMed ID: 10543292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dry powder inhalers in cystic fibrosis].
    Steinkamp G
    Pneumologie; 2014 Jun; 68(6):378-85. PubMed ID: 24664997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of safety and tolerability of inhaled hypertonic saline in infants with cystic fibrosis.
    Subbarao P; Balkovec S; Solomon M; Ratjen F
    Pediatr Pulmonol; 2007 May; 42(5):471-6. PubMed ID: 17436328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy.
    App EM; King M; Helfesrieder R; Köhler D; Matthys H
    Am Rev Respir Dis; 1990 Mar; 141(3):605-12. PubMed ID: 2310093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis.
    Eng PA; Morton J; Douglass JA; Riedler J; Wilson J; Robertson CF
    Pediatr Pulmonol; 1996 Feb; 21(2):77-83. PubMed ID: 8882210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled Mannitol (Bronchitol) for Cystic Fibrosis.
    Nolan SJ; Thornton J; Murray CS; Dwyer T
    Paediatr Respir Rev; 2016 Mar; 18():52-4. PubMed ID: 26867712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.